MIM
BNGO icon

Monashee Investment Management’s Bionano Genomics BNGO Stock Holding History

Monashee Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-138
Closed -$59K – 89
2019
Q3 		$59K Hold
138
– – 0.03% 107
2019
Q2 		$202K Hold
138
– – 0.05% 145
2019
Q1 		$360K Sell
138
-272
-66% -$713K 0.08% 113
2018
Q4 		$1.29M Buy
+410
New +$1.63M 0.87% 35
2018
Q3 		– Hold
0
– – – 95

Other funds holding BNGO

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Monashee Investment Management's BNGO Position: Q4 2019 in Review

Monashee Investment Management sold out of Bionano Genomics (BNGO) in Q4 2019, closing a stake of 138 shares — an estimated $59K sold.

Monashee Investment Management first reported a position in BNGO in Q4 2018 and held it in 4 quarters. The position peaked at $1.29M in Q4 2018. 9 funds tracked by Wall St. Rank hold BNGO as of Q4 2019.

  • Monashee Investment Management reported no remaining Bionano Genomics position as of Q4 2019 after selling out during the quarter.
  • Monashee Investment Management sold 138 Bionano Genomics shares in Q4 2019, an estimated $59K.
  • Monashee Investment Management first reported a position in Bionano Genomics in Q4 2018 and held it in 4 quarters.
  • Monashee Investment Management's Bionano Genomics position peaked at $1.29M in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2019.

Based on Monashee Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.